DK1835907T3 - Lægemidler til behandling eller forebyggelse af fibrotiske sygdomme - Google Patents
Lægemidler til behandling eller forebyggelse af fibrotiske sygdommeInfo
- Publication number
- DK1835907T3 DK1835907T3 DK05823903T DK05823903T DK1835907T3 DK 1835907 T3 DK1835907 T3 DK 1835907T3 DK 05823903 T DK05823903 T DK 05823903T DK 05823903 T DK05823903 T DK 05823903T DK 1835907 T3 DK1835907 T3 DK 1835907T3
- Authority
- DK
- Denmark
- Prior art keywords
- medicines
- treating
- fibrotic diseases
- preventing fibrotic
- preventing
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000003176 fibrotic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04030769 | 2004-12-24 | ||
| PCT/EP2005/057013 WO2006067175A1 (en) | 2004-12-24 | 2005-12-21 | Medicaments for the treatment or prevention of fibrotic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1835907T3 true DK1835907T3 (da) | 2009-08-03 |
Family
ID=35717457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05823903T DK1835907T3 (da) | 2004-12-24 | 2005-12-21 | Lægemidler til behandling eller forebyggelse af fibrotiske sygdomme |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20060148883A1 (da) |
| EP (1) | EP1835907B1 (da) |
| JP (1) | JP5748386B2 (da) |
| KR (1) | KR20070092305A (da) |
| CN (1) | CN101087604B (da) |
| AR (1) | AR052439A1 (da) |
| AT (1) | ATE429222T1 (da) |
| AU (1) | AU2005318136B2 (da) |
| BR (1) | BRPI0519351A2 (da) |
| CA (1) | CA2591089C (da) |
| DE (1) | DE602005014145D1 (da) |
| DK (1) | DK1835907T3 (da) |
| EA (1) | EA200701181A1 (da) |
| ES (1) | ES2326277T3 (da) |
| HR (1) | HRP20090312T1 (da) |
| IL (1) | IL184124A0 (da) |
| MX (1) | MX2007007676A (da) |
| NO (1) | NO20073830L (da) |
| PE (1) | PE20061155A1 (da) |
| PL (1) | PL1835907T3 (da) |
| PT (1) | PT1835907E (da) |
| RS (1) | RS50833B (da) |
| SI (1) | SI1835907T1 (da) |
| TW (1) | TW200637544A (da) |
| WO (1) | WO2006067175A1 (da) |
| ZA (1) | ZA200703600B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7514468B2 (en) * | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
| US7169936B2 (en) * | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| WO2007057399A2 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer with indole derivatives |
| US8501646B2 (en) * | 2007-03-02 | 2013-08-06 | Mitsui Chemicals, Inc. | Non-woven fabric laminate |
| EP2220079A2 (en) * | 2007-11-15 | 2010-08-25 | Boehringer Ingelheim International GmbH | Substituted amides, manufacturing and use thereof as medicaments |
| US20090131359A1 (en) * | 2007-11-19 | 2009-05-21 | Atamas Sergei P | Antifibrotic therapy |
| DK2238108T3 (da) * | 2008-01-25 | 2012-10-15 | Boehringer Ingelheim Int | Saltformer af et 6-fluor-1,2-dihydro-2-oxo-3h-indol-3-yliden-derivat, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende de samme |
| JP2012503619A (ja) | 2008-09-26 | 2012-02-09 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Ｈｃｖ感染に対する抗ウイルス治療のための標的としての宿主細胞キナーゼ |
| WO2012103520A1 (en) * | 2011-01-28 | 2012-08-02 | Board Of Regents Of The University Of Nebraska | Methods and compositions for modulating cyclophilin d |
| US10450295B2 (en) | 2013-08-09 | 2019-10-22 | Acclaim BioMed USA LLC | Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| PT3691620T (pt) | 2017-10-05 | 2022-10-06 | Fulcrum Therapeutics Inc | Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE243195T1 (de) * | 1998-09-25 | 2003-07-15 | Boehringer Ingelheim Pharma | Neue substituierte indolinone mit einer inhibierenden wirkung auf verschiedene kinasen und cyclin/cdk-komplexe |
| US6762180B1 (en) * | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
| DE10117204A1 (de) * | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US7169936B2 (en) * | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
| PE20040701A1 (es) * | 2002-07-23 | 2004-11-30 | Boehringer Ingelheim Pharma | Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos |
-
2005
- 2005-12-16 PE PE2005001477A patent/PE20061155A1/es not_active Application Discontinuation
- 2005-12-20 US US11/275,226 patent/US20060148883A1/en not_active Abandoned
- 2005-12-21 AU AU2005318136A patent/AU2005318136B2/en not_active Ceased
- 2005-12-21 DK DK05823903T patent/DK1835907T3/da active
- 2005-12-21 ES ES05823903T patent/ES2326277T3/es active Active
- 2005-12-21 PT PT05823903T patent/PT1835907E/pt unknown
- 2005-12-21 JP JP2007547510A patent/JP5748386B2/ja not_active Expired - Fee Related
- 2005-12-21 BR BRPI0519351-6A patent/BRPI0519351A2/pt not_active IP Right Cessation
- 2005-12-21 KR KR1020077017059A patent/KR20070092305A/ko not_active Application Discontinuation
- 2005-12-21 SI SI200530719T patent/SI1835907T1/sl unknown
- 2005-12-21 EP EP05823903A patent/EP1835907B1/en active Active
- 2005-12-21 RS RSP-2009/0245A patent/RS50833B/sr unknown
- 2005-12-21 PL PL05823903T patent/PL1835907T3/pl unknown
- 2005-12-21 AT AT05823903T patent/ATE429222T1/de active
- 2005-12-21 CN CN2005800446331A patent/CN101087604B/zh not_active Expired - Fee Related
- 2005-12-21 MX MX2007007676A patent/MX2007007676A/es active IP Right Grant
- 2005-12-21 CA CA2591089A patent/CA2591089C/en not_active Expired - Fee Related
- 2005-12-21 WO PCT/EP2005/057013 patent/WO2006067175A1/en active Application Filing
- 2005-12-21 DE DE602005014145T patent/DE602005014145D1/de active Active
- 2005-12-21 EA EA200701181A patent/EA200701181A1/ru unknown
- 2005-12-22 AR ARP050105467A patent/AR052439A1/es unknown
- 2005-12-23 TW TW094146423A patent/TW200637544A/zh unknown
-
2007
- 2007-05-04 ZA ZA200703600A patent/ZA200703600B/en unknown
- 2007-06-21 IL IL184124A patent/IL184124A0/en unknown
- 2007-07-23 NO NO20073830A patent/NO20073830L/no not_active Application Discontinuation
-
2009
- 2009-05-27 HR HR20090312T patent/HRP20090312T1/xx unknown
-
2011
- 2011-03-31 US US13/077,138 patent/US20120004202A1/en not_active Abandoned
-
2014
- 2014-01-13 US US14/153,542 patent/US20140128409A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL1835907T3 (pl) | 2009-08-31 |
| JP5748386B2 (ja) | 2015-07-15 |
| CN101087604A (zh) | 2007-12-12 |
| AU2005318136A1 (en) | 2006-06-29 |
| JP2008525374A (ja) | 2008-07-17 |
| EP1835907A1 (en) | 2007-09-26 |
| AR052439A1 (es) | 2007-03-21 |
| US20060148883A1 (en) | 2006-07-06 |
| CA2591089A1 (en) | 2006-06-29 |
| HRP20090312T1 (en) | 2009-07-31 |
| TW200637544A (en) | 2006-11-01 |
| EA200701181A1 (ru) | 2008-02-28 |
| CA2591089C (en) | 2014-02-11 |
| IL184124A0 (en) | 2007-10-31 |
| BRPI0519351A2 (pt) | 2009-01-20 |
| ES2326277T3 (es) | 2009-10-06 |
| DE602005014145D1 (de) | 2009-06-04 |
| RS50833B (sr) | 2010-08-31 |
| ATE429222T1 (de) | 2009-05-15 |
| KR20070092305A (ko) | 2007-09-12 |
| US20120004202A1 (en) | 2012-01-05 |
| PE20061155A1 (es) | 2006-12-16 |
| EP1835907B1 (en) | 2009-04-22 |
| NO20073830L (no) | 2007-07-23 |
| US20140128409A1 (en) | 2014-05-08 |
| ZA200703600B (en) | 2008-07-30 |
| WO2006067175A1 (en) | 2006-06-29 |
| AU2005318136B2 (en) | 2012-02-09 |
| CN101087604B (zh) | 2010-10-13 |
| SI1835907T1 (sl) | 2009-10-31 |
| PT1835907E (pt) | 2009-06-16 |
| MX2007007676A (es) | 2007-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1835907T3 (da) | Lægemidler til behandling eller forebyggelse af fibrotiske sygdomme | |
| DK1830843T3 (da) | Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme | |
| DK1720571T3 (da) | Fremgangsmåde til behandling af hæmolytisk sygdom | |
| NL1029015A1 (nl) | Therapeutische verbindingen. | |
| DK1598097T3 (da) | Byggesystem | |
| NO20070251A (no) | Brønnbehandling | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| DK1833532T3 (da) | Sikkerhedssprøjte | |
| NO20070297A (no) | Brønnbehandling | |
| DE602005023954D1 (de) | Hubsystem | |
| DK1942967T3 (da) | Fremgangsmåde til dosering af medikamenter | |
| DK1757293T3 (da) | Bh4-responsiv hyperphenylalaninæmi-medikamenter | |
| FI20041690A0 (fi) | Hissijärjestelmä | |
| DE602004011999D1 (de) | Mehrbenutzer-übertragungssystem | |
| DK1814555T3 (da) | S-mirtazapin til behandling af hedeture | |
| DK1600416T3 (da) | Løftesystem | |
| FI20040796A0 (fi) | Hissijärjestelmä | |
| NL1028040A1 (nl) | Gebogen athermische pseudokinematische standaard. | |
| LU91202B1 (de) | Palisadensystem | |
| ES1058167Y (es) | Pasacables. | |
| FI20040981A0 (fi) | Turvalaite | |
| FI20040328A0 (fi) | Hissijärjestelmä | |
| ES1058102Y (es) | Lentilla terapeutica. | |
| DE112005002941A5 (de) | Liftanlage | |
| FI6455U1 (fi) | Virtuaali-ikkunajärjestelmä |